CP Axtra (CPAXT) Earnings Soar: 2Q Net Income Jumps 45% to 2.18B Baht

CP Axtra on Smartkarma

Analyst coverage of CP Axtra on Smartkarma has been positive, with Angus Mackintosh publishing a bullish report titled “CP Axtra (CPAXT TB) – Symbiotic Alliance.” According to the report, CP Axtra offers an alternative retail exposure to its parent company CP ALL, with ongoing restructuring benefits yet to be fully realized. The company’s valuations are deemed attractive relative to its growth prospects. CP Axtra is described as a merger combining the Makro wholesale business, Lotus hypermarket and supermarket businesses, and a hybrid mall operation. The entity is said to be achieving operational synergies in sourcing and logistics, with a significant B2B element. The report highlights that omnichannel sales account for over 16% of revenue and are experiencing rapid growth.

A look at CP Axtra Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Investors looking at the long-term outlook for CP Axtra will find a company that has received positive Smart Scores across various factors. The company’s strong momentum score of 4 indicates a promising upward trend, while its values, growth, and resilience scores also sit at respectable levels. Although the dividend score is slightly lower, the overall outlook for CP Axtra seems optimistic based on these Smart Scores.

CP Axtra Public Company Limited, a retail discount store chain based in Thailand, caters to a diverse customer base including wholesalers, retailers, small businesses, caterers, and individual members. With its solid Smart Scores in key aspects such as momentum, value, growth, and resilience, CP Axtra appears positioned for potential long-term success in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma